We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Identifying Gene Interactions Through Single-Cell Imaging

By LabMedica International staff writers
Posted on 04 Mar 2010
Cellular imaging provides a huge amount of data about how cells respond to stimuli, but harnessing this technique to study biologic systems is an overwhelming challenge. More...
In a recent study, researchers have developed an innovative method of interpreting data from single-cell images to identify genetic interactions within biologic networks, offering a glimpse into the future of high-throughput cell imaging analysis.

For years, scientists have been looking through a microscope at cells as they change appearance in response to different treatments, yet data collection is time-consuming, largely conducted qualitatively by eye. However, recent technologic developments have led to the development of high-throughput image screening methods that can produce extensive datasets of hundreds of different morphologic features.

With the ability to collect large imaging datasets, researchers from the Massachusetts Institute of Technology (MIT; Cambridge, MA, USA) and Harvard Medical School (Boston, MA, USA) recognized an opportunity to explore the cellular networks that regulate cell morphology. "These images are an enormous source of data that is only beginning to be tapped,” said MIT researcher Dr. Bonnie Berger, senior author of the study, which was published online in February 9, 2010, in the journal Genome Research. "We realized we had enough data to go beyond classification and start to understand the mechanism behind the differences in shape.”

To meet the challenge of interpreting cell image data, Dr. Berger and MIT graduate student Oaz Nir developed an innovative computational model to identify genetic interactions using high-dimensional morphologic data. The model, integrating prerequisite knowledge of a pathway, maps potential interactions within a network by looking for similar morphologic characteristics upon genetic perturbation.

The group demonstrated the method by analyzing the Rho-signaling network in fruit flies, a network that regulates cell adhesion and motility in eukaryotic organisms. In collaboration with Dr. Chris Bakal and Dr. Norbert Perrimon at Harvard Medical School, they "knocked-down” components of the Rho-signaling network using RNA interference and then imaged thousands of fly cells, collecting measurements of cell perimeter, nuclear area, and more than 150 other morphologic features for each cell. The data were then passed through the computational framework to generate a set of high-confidence interactions, supported by confirmation of previously known interactions.

The investigators discovered that by making combinatorial knockdowns of Rho network components, their computational method was able to accurately infer Rho-signaling network interactions more precisely than when using only data from single knockdowns. Dr. Berger noted that this finding highlights the importance of combinatorial experiments for inferring complex networks, necessary to overcome natural redundancy in signaling pathways. As perturbation of the Rho pathway in humans has been implicated in cancer and other diseases, the scientists believe that these predicted interactions will be excellent candidates for future study.

Dr. Berger expects that in combination with other sources of data, imaging as a new source of high-throughput data should appreciably increase the accuracy of known signaling networks. "This work provides a glimpse into the future,” added Dr. Berger, "where looking under the microscope manually at cells one-by-one is replaced with automated high-throughput processing of many cellular images.”

Related Links:
Massachusetts Institute of Technology
Harvard Medical School


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Serological Pipet Controller
PIPETBOY GENIUS
New
Hand-Held Immunofluorescence Analyzer
WS-Si1500
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.